CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease
Not Applicable
Recruiting
- Conditions
- Leptomeningeal MetastasisEGFR Activating MutationNon Small Cell Lung Cancer
- Interventions
- Diagnostic Test: Lumbar puncture and Phlebotomy
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT05257967
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
Not Applicable
Recruiting
- Conditions
- HyperglycemiaPDAC - Pancreatic Ductal AdenocarcinomaPancreatic Cancer
- Interventions
- Other: Standard CareProcedure: Endocrinologist-directed target blood glucose level 4-10 mmol/L using data from a continuous glucose monitor (CGM)
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 50
- Registration Number
- NCT05132244
- Locations
- 🇨🇦
British Columbia Cancer, Vancouver, British Columbia, Canada
PRecision Oncology Evidence Development in Cancer Treatment - Liquid
Not Applicable
Active, not recruiting
- Conditions
- Cancer
- Interventions
- Diagnostic Test: FoundationOne liquid CDxBehavioral: Quality of life questionnaires
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 1500
- Registration Number
- NCT05057234
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
RAPid SimPLE Targeted Radiation Treatment for Brain Metastases
Phase 2
Recruiting
- Conditions
- Brain Metastases, Adult
- Interventions
- Radiation: Targeting All Brain Metastases
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 100
- Registration Number
- NCT05050929
- Locations
- 🇨🇦
BC Cancer - Abbotsford, Abbotsford, British Columbia, Canada
🇨🇦BC Cancer - Kelowna, Kelowna, British Columbia, Canada
🇨🇦BC Cancer - Prince George, Prince George, British Columbia, Canada
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
Recruiting
- Conditions
- AscitesOvarian Cancer
- Interventions
- Dietary Supplement: [U-13C]Glucose
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT05025878
- Locations
- 🇨🇦
Jennifer Rauw, Victoria, British Columbia, Canada
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Phase 2
Withdrawn
- Conditions
- Neuroendocrine TumorsCarcinoid TumorGastrinomaPulmonary Carcinoid TumorGastroenteropancreatic Neuroendocrine TumorVipomaInsulinoma
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- British Columbia Cancer Agency
- Registration Number
- NCT04915144
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
Not Applicable
- Conditions
- Prostatic NeoplasmUrogenital NeoplasmsNeoplasmsProstate CancerProstatic DiseaseDisease Attributes
- Interventions
- Other: [68Ga]Ga-HTK03149 PET/CT
- First Posted Date
- 2021-04-05
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT04831307
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
Not Applicable
Recruiting
- Conditions
- Cancer
- Interventions
- Behavioral: QOLDiagnostic Test: CT imaging
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 30
- Registration Number
- NCT04814095
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Phase 2
Recruiting
- Conditions
- Ovarian CancerPlatinum-resistant Ovarian Cancer
- Interventions
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 244
- Registration Number
- NCT04787289
- Locations
- 🇨🇦
Abbotsford Centre, BC Cancer Agency, Abbotsford, British Columbia, Canada
🇨🇦BC Cancer - Vancouver, Vancouver, British Columbia, Canada
Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath
- Conditions
- Covid19
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 1000
- Registration Number
- NCT04714333
- Locations
- 🇨🇦
BC Cancer Research Centre, Vancouver, British Columbia, Canada
🇨🇦British Columbia Research Centre, Vancouver, British Columbia, Canada
© Copyright 2025. All Rights Reserved by MedPath